Corporate Fear Drives Caribbean Vaccine COVID-19 Mandates

The private sector and some government agencies have demanded that staff vaccinate, especially in the tourism industry that drives many regional economies. Credit: Zadie Neufville/IPSBy Zadie NeufvilleKINGSTON, Nov 22 2021 (IPS) When face-to-face Cabinet meetings resumed in Jamaica following more than a year of virtual meetings due to COVID-19, Ministers lined up to have their immunisation cards inspected. Prime Minister Andrew Holness said the Government “has to lead the country towards normality”. “The way to do it is for every Jamaican to comply with the infection, prevention and control measures that have been established, which will eventually be relaxed the higher the level of vaccination,” he said after the October 12 meeting. In the current atmosphere, outbreaks, no-movement days that shut down commerce and vaccine hesitancy send ripples through the economy. So, while Jamaica has no national vaccine mandate, private sector companies and some government agencies are already demanding that staff vaccinate. In addition to several vaccination drives that target employees, Jamaica Private Sector Organisation joined the Jamaica Chamber of Commerce and the Jamaica Manufacturers and Exporters Association to put their support solidly behind a campaign for a national mandate. The groups say that with the low vaccination rates almost two years into the pandemic, Jamaica is being left behind in achieving population immunity, putting the country’s ...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: COVID-19 COVID-19 VACCINES Development & Aid Economy & Trade Featured Financial Crisis Headlines Health Latin America & the Caribbean TerraViva United Nations Trade & Investment Source Type: news

Related Links:

With UK nations set to remove some or all COVID-19 restrictions in the coming days and weeks, UNISON is urging employers not to let their guard down, but to continue to comply with health and safety legislation, including their duties to identify and reduce risks for their employees. The legislation lays out requirements that employers, among other things, regularly review risk assessments, consult with union health and safety representatives and be ready to put additional measures in place. There are also duties on employers, under the Workplace (Health, Safety and Welfare) Regulations 1992, which require them to ens...
Source: UNISON Health care news - Category: UK Health Authors: Tags: Article News Covid-19 health and safety Source Type: news
In this study, Metadichol® was found to be 270 times more potent an inhibitor of TMPRSS2 (EC50 = 96 ng/mL) than camostat mesylate (EC50 = 26000 ng/mL). Additionally, it inhibits ACE with an EC50 of 71 ng/mL, but it is a very weak inhibitor of ACE2 at an EC50 of 31 μg/mL. Furthermore, the live viral assay performed in Caco-2 cells revealed that Metadichol® inhibits SARS-CoV-2 replication at an EC90 of 0.16 μg/mL. Moreover, Metadichol® had an EC90 of 0.00037 μM, making it 2081 and 3371 times more potent than remdesivir (EC50 = 0.77 μM) and chloroquine (EC50 = 1.14 μM), respectively.PMID:35039793 | ...
Source: Cell Research - Category: Cytology Authors: Source Type: research
This study demonstrates the viral genotypes can be utilized as molecular barcodes in combination with epidemiologic data to monitor the spreading routes of the pandemic and evaluate the effectiveness of control measures. Moreover, the dynamics of viral mutational spectrum in the study may help the early identification of new strains in patients to reduce further spread of infection, guide the development of molecular diagnosis and vaccines against COVID-19, and help assess their accuracy and efficacy in real world at real time. This article is protected by copyright. All rights reserved.PMID:35001392 | DOI:10.1002/jmv.27580
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research
Biosens Bioelectron. 2021 Dec 23;200:113909. doi: 10.1016/j.bios.2021.113909. Online ahead of print.ABSTRACTCoronavirus disease 2019 (COVID-19) has been recognized as a global pandemic outbreak, opening the most severe socio-economic crisis since World War II. Different scientific activities have been emerged in this global scenario, including the development of innovative analytical tools to measure nucleic acid, antibodies, and antigens in the nasopharyngeal swab, serum, and saliva for prompt identification of COVID-19 patients and to evaluate the immune response to the vaccine. The detection of SARS-CoV-2 in saliva rema...
Source: Biosensors and Bioelectronics - Category: Biotechnology Authors: Source Type: research
NEW BRUNSWICK, N.J., January 6, 2022 – Johnson &Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson &Johnson COVID-19 vaccine resulted in long-lasting protection for up to six months against COVID-19 breakthrough infections, hospitalizations, and intensive care unit (ICU) admissions. The study was sponsored by the Janssen Pharmaceutical Companies of Johnson &Johnson and conducted in partnership with the Department of Science-Aetion, Inc, and the Division of...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Mol Biol Rep. 2022 Jan 6:1-10. doi: 10.1007/s11033-021-07020-6. Online ahead of print.ABSTRACTCoronavirus outbreak was declared a pandemic by World Health Organization (WHO) in March 2020. The pandemic has led to a devastating loss of life. It has shown us how infectious diseases can cause human existence at stake, and community health is important. The spike protein is the most immunogenic component of the virus. Most vaccine development strategies have focused on the receptor-binding domain (RBD) in the spike protein because it is the most specific target site that recognizes and interacts with human lung cells. Neutrali...
Source: Molecular Biology Reports - Category: Molecular Biology Authors: Source Type: research
[Nigeria Health Watch] From the moment the novel coronavirus was identified in January 2020 and subsequently declared a pandemic in March, the race has been on to control the outbreak. Governments around the world locked down their countries and advised on tough public health and social measures for self-protection and to protect loved ones, as well as to limit the spread of the virus. These all came at great economic cost.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Acta Virol. 2021;65(4):350-364. doi: 10.4149/av_2021_409.ABSTRACTZoonotic transmission of highly pathogenic viruses, are a cause of deadly epidemics around the globe. These are of particular concern as evident from the recent global pandemic due to Coronavirus disease 2019 (COVID-19). The genus Ebolavirus belongs to the Filoviridae family and its members are known to cause the Ebola virus disease (EVD), a highly contagious disease with a mortality rate of approximately 90%. The similarity of the clinical symptoms to those of various tropical ailments poses a high risk of misdiagnosis. Diagnostic strategies currently utiliz...
Source: Acta Virologica - Category: Infectious Diseases Authors: Source Type: research
Preparation means not just improving surveillance and buying more protective gear, but rethinking the way we liveThough at times it can feel hard to believe – especially in recent weeks, perhaps –this pandemic will not last for ever. With more than 5 million dead and hugeeconomic and social costs, its toll has been immense, and unnecessarily so. Secrecy in China, complacency in Europe, reckless and callous rightwing populism in the US and Brazil, and the inequity in vaccine distribution have all contributed.Yet if we learn its lessons, we will be better prepared next time. For there will be a next time. Covid i...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus Infectious diseases Medical research Microbiology Global economy Economics Sars Wildlife Antibiotics Source Type: news
Emily Baldwin remembers the morning she realized that the COVID-19 pandemic was going to make her job more difficult. It was the spring of 2020, and the novel coronavirus was raging on the east coast but had yet to overtake West Virginia. A man rushed into the Milan Puskar Health Right clinic in Morgantown and said he thought there was someone dead in an alley about a block away. Baldwin, who is a nurse and the coordinator for the clinic’s harm reduction program, ran outside and quickly realized a young man was overdosing. She sprinted back to the clinic, grabbed Narcan, a medication that can reverse overdoses, then...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
More News: Antigua and Barbuda Health | Bahamas Health | Barbados Health | Coronavirus | COVID-19 | Economy | Education | Environmental Health | Eyes | Government | Grenada Health | Guyana Health | Health Management | International Medicine & Public Health | Jamaica Health | Lawsuits | Legislation | Outbreaks | Pandemics | Teachers | Trinidad and Tobago Health | United Nations | Universities & Medical Training | Vaccines | Zimbabwe Health